Hematologic Malignancy
Rosai-Dorfman-Destombes Disease
CI-CAN-00001469RDD · SHMLExplore in graph →
HematologicNon-malignant3 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001469RDD · SHMLExplore in graph →
Clinical trials
5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05915208 | Histiocytic Disorder Follow-up Study | recruiting | — | 6,000 | University of Alabama at BirminghamOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05093335 | In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET | recruiting | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06712810 | Q702 for the Treatment of Patients With Hematologic Malignancies | recruiting | Phase 1 | 46 | Mayo ClinicOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT04079179 | Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders(NACHO-COBI) | recruiting | Phase 2 | 90 | Carl AllenOTHER |
Data updated 22 days agoSource updated Jun 12, 2026source: clinicaltrials
| 1 |
| Sep 18, 2025 |
| clinicaltrials |
| NCT02285582 | International Rare Histiocytic Disorders Registry (IRHDR)(IRHDR) | recruiting | — | 400 | The Hospital for Sick ChildrenOTHER | 9 | Jun 24, 2025 | clinicaltrials |